Articles producció científica> Bioquímica i Biotecnologia

Cyclodextrin mediated delivery of NF-κB and SRF siRNA reduces the invasion potential of prostate cancer cells in vitro

  • Dades identificatives

    Identificador: imarina:6388360
    Autors:
    Evans JMcCarthy JTorres-Fuentes CCryan JOgier JDarcy RWatson RO'Driscoll C
    Resum:
    © 2015 Macmillan Publishers Limited All rights reserved. Prostate cancer is the most common cancer in men of the western world. To date, no effective treatment exists for metastatic prostate cancer and consequently, there is an urgent need to develop new and improved therapeutics. In recent years, the therapeutic potential of RNA interference (RNAi) has been extensively explored in a wide range of diseases including prostate cancer using numerous gene delivery vectors. The aims of this study were to investigate the ability of a non-viral modified cyclodextrin (CD) vector to deliver siRNA to the highly metastatic PC-3 prostate cancer cell line, to quantify the resulting knockdown of the two target genes (RelA and SRF) and to study the effects of the silencing on metastasis. Data from a Matrigel in vitro invasion assay indicated that the silencing of the target genes achieved by the CD vector resulted in significant reductions (P=0.0001) in the metastatic potential of these cells. As the silencing of these target genes was shown not to have a negative impact on cell viability, we hypothesise that the mechanism of invasion inhibition is due, in part, to the significant reduction observed (P≤0.0001) in the level of pro-inflammatory cytokine, MMP9, which is known to be implicated in the metastasis of prostate cancer.
  • Altres:

    Autor segons l'article: Evans J; McCarthy J; Torres-Fuentes C; Cryan J; Ogier J; Darcy R; Watson R; O'Driscoll C
    Departament: Bioquímica i Biotecnologia
    Autor/s de la URV: Torres Fuentes, Cristina
    Paraules clau: Good health and well-being
    Resum: © 2015 Macmillan Publishers Limited All rights reserved. Prostate cancer is the most common cancer in men of the western world. To date, no effective treatment exists for metastatic prostate cancer and consequently, there is an urgent need to develop new and improved therapeutics. In recent years, the therapeutic potential of RNA interference (RNAi) has been extensively explored in a wide range of diseases including prostate cancer using numerous gene delivery vectors. The aims of this study were to investigate the ability of a non-viral modified cyclodextrin (CD) vector to deliver siRNA to the highly metastatic PC-3 prostate cancer cell line, to quantify the resulting knockdown of the two target genes (RelA and SRF) and to study the effects of the silencing on metastasis. Data from a Matrigel in vitro invasion assay indicated that the silencing of the target genes achieved by the CD vector resulted in significant reductions (P=0.0001) in the metastatic potential of these cells. As the silencing of these target genes was shown not to have a negative impact on cell viability, we hypothesise that the mechanism of invasion inhibition is due, in part, to the significant reduction observed (P≤0.0001) in the level of pro-inflammatory cytokine, MMP9, which is known to be implicated in the metastasis of prostate cancer.
    Àrees temàtiques: Pharmacology & pharmacy Odontología Molecular medicine Molecular biology Medicine, research & experimental Medicina iii Medicina i Genetics & heredity Genetics General medicine Ciências biológicas iii Biotechnology & applied microbiology Biochemistry & molecular biology
    Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
    ISSN: 09697128
    Adreça de correu electrònic de l'autor: cristina.torres@urv.cat
    Identificador de l'autor: 0000-0002-2917-6910
    Data d'alta del registre: 2024-11-16
    Versió de l'article dipositat: info:eu-repo/semantics/acceptedVersion
    Enllaç font original: https://www.nature.com/articles/gt201550
    URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
    Referència a l'article segons font original: Gene Therapy. 22 (10): 802-810
    Referència de l'ítem segons les normes APA: Evans J; McCarthy J; Torres-Fuentes C; Cryan J; Ogier J; Darcy R; Watson R; O'Driscoll C (2015). Cyclodextrin mediated delivery of NF-κB and SRF siRNA reduces the invasion potential of prostate cancer cells in vitro. Gene Therapy, 22(10), 802-810. DOI: 10.1038/gt.2015.50
    DOI de l'article: 10.1038/gt.2015.50
    Entitat: Universitat Rovira i Virgili
    Any de publicació de la revista: 2015
    Tipus de publicació: Journal Publications
  • Paraules clau:

    Biochemistry & Molecular Biology,Biotechnology & Applied Microbiology,Genetics,Genetics & Heredity,Medicine, Research & Experimental,Molecular Biology,Molecular Medicine,Pharmacology & Pharmacy
    Good health and well-being
    Pharmacology & pharmacy
    Odontología
    Molecular medicine
    Molecular biology
    Medicine, research & experimental
    Medicina iii
    Medicina i
    Genetics & heredity
    Genetics
    General medicine
    Ciências biológicas iii
    Biotechnology & applied microbiology
    Biochemistry & molecular biology
  • Documents:

  • Cerca a google

    Search to google scholar